Jiangang Zhang | Cell Metabolism | Research Excellence Award

Dr. Jiangang Zhang | Cell Metabolism | Research Excellence Award

School of Basic Medical Sciences, Lanzhou University | China

Dr. Jiangang Zhang. A senior academic and medical professional with extensive leadership in pathology, forensic medicine, and laboratory sciences at Lanzhou University and its affiliated hospitals. Holds multiple directorial roles across pathology departments, forensic appraisal institutes, dental hospitals, and GLP laboratory centers, contributing significantly to clinical diagnostics, forensic evaluation, and translational research. Recognized nationally and provincially as an expert in forensic appraisal, including insurance-related forensic assessments, and plays a key role in expert review and governance bodies. Academic training spans clinical medicine, tissue engineering, and advanced biomedical research, with doctoral-level experience at Peking University. Research expertise includes obesity, nutrition, chronic diseases, skin tissue engineering, and pathology-related biomedical sciences. Has led and completed several major nationally funded research projects, including multiple grants from the National Natural Science Foundation of China and military medical research programs, reflecting sustained contributions to medical science, education, and forensic pathology.

Citation Metrics (Scopus)

300
200
100
50
0

Citations
252

Documents
14

h-index
6

Citations

Documents

h-index

Featured Publication

Ji Cao | Macrophage Biology | Research Excellence Award

Prof. Ji Cao | Macrophage Biology | Research Excellence Award

Zhejiang University | China

Ji Cao, Ph.D., is a leading scholar in tumor pharmacology and anticancer drug discovery, internationally recognized as a World’s Top 2% Scientist (Stanford ranking, 2023) and a National Young Top Talent of China. His research integrates tumor pharmacology, chemical biology, and artificial intelligence–driven drug design, with major contributions to targeted protein degradation (PROTACs), ferroptosis regulation, MYC oncoprotein inhibition, and cancer immunotherapy. He has published over 59 peer-reviewed articles in high-impact journals such as Cell Metabolism, Nature Communications, PNAS, and Science Advances, including multiple ESI highly cited papers, accumulating more than 4,000 citations with an h-index of 36. His work has translated into innovation through 18 Chinese patents and one international patent. He has led nationally and provincially funded projects exceeding ¥14 million and has received prestigious science and technology awards for outstanding contributions to biomedical research and translational pharmacology.

Citation Metrics (Scopus)

6000
4000
2000
200
100
50
0

Citations
5,725

Documents
149

h-index
44

Citations

Documents

h-index

Featured Publication

Insoon Chang | Tissue Engineering Regeneration | Research Excellence Award

Assist. Prof. Dr. Insoon Chang | Tissue Engineering Regeneration | Research Excellence Award

UCLA School of Dentistry | United States

Insoon Chang is a tenure-track Assistant Professor in Endodontics at a leading dental academic institution and a board-certified endodontist with a strong profile as a dual-trained clinician-scientist. Their work integrates clinical endodontics with translational and basic research, with primary expertise in regenerative endodontics, osteoimmunology, tissue regeneration, and inflammatory disease–associated healing. Research contributions span molecular biology, epigenetics, animal models, and clinically relevant systems, aiming to advance endogenous cell-mediated strategies for pulp–dentin complex regeneration. Completed studies have addressed epigenetic regulation of mesenchymal stem cells in osteoporosis and aging, as well as mechanisms of tumorigenesis and progression in head and neck squamous cell carcinoma. Ongoing research focuses on osteoimmune dysregulation in uncontrolled type II diabetes and innovative regenerative approaches using minced dental pulp transplantation. The scholarly output includes over 20 peer-reviewed publications in high-impact SCI/SCIE and Scopus-indexed journals across dentistry, cell biology, cancer research, and regenerative medicine. In addition to research, significant contributions are made to graduate and advanced clinical education, mentoring, program leadership, and interdisciplinary collaboration. Active national and international collaborations support translational and basic research efforts, positioning this work at the interface of clinical relevance and fundamental biological discovery.

Citation Metrics (Scopus)
600
400
200
0
Citations
592
Documents
16
h-index
8
Citations
Documents
h-index


View Scopus Profile

Featured Publications

Sakarie Mustafe Hidig | Cancer Cell Biology | Research Excellence Award

Dr. Sakarie Mustafe Hidig | Cancer Cell Biology | Research Excellence Award

Zhejiang University School of Medicine | United Kingdom

Dr. Sakarie Mustafe Hidig is a General Surgeon, Clinical Researcher, and Editor-in-Chief affiliated with Zhejiang University School of Medicine and the Research Center at Hargeisa Group Hospital. He serves as the UK Country Coordinator for the International Institute of Knowledge Management (TIIKM) and is an active member of the China Medical Association, Somali Medical Association, and the Scholars Academic and Scientific Society. Dr. Hidig has earned multiple international honors, including the SHEN Best Researcher Awards, GCDMSE-2024, and ISSN Research Awards. With over 70 published papers, 280+ SCI editorial handling experiences, and 14 research projects, his work spans general, gastrointestinal, trauma, emergency, hepatobiliary, and pancreatic surgery. He also contributes as an editor for major journals such as PLOS One Medicine, Annals of Medicine and Surgery, Obesity Surgery, and JMIR Public Health and Surveillance. His research interests include surgical oncology, hepatology, pancreatic cancer, and public health.

Citation Metrics (Scopus)

40

30

20

10

0

Citations
12

Documents
7

h-index
2

Citations
Documents
h-index



View Scopus Profile

Featured Publication

Lin Wu | Bone Tissue Engineering | Excellence in Research Award

Ms. Lin Wu | Bone Tissue Engineering | Excellence in Research Award

Department of Stomatology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, P.R | China

Professor Wu Lin is a leading scholar in oral rehabilitation and biomaterials research, recognized for her extensive contributions to bone implant materials and advanced technologies for dental restoration. Her work spans more than 90 peer-reviewed publications across high-impact national and international journals, reflecting sustained productivity and influence in stomatology research. She has led major scientific initiatives, including national natural science projects, a “14th Five-Year Plan” National Key R&D project, national disaster-related research, multiple sub-projects under the national “863” Plan, and several provincial-level grants. As the first inventor, she holds two authorized invention patents that advance the design and performance of oral implant systems. Her editorial roles in multiple scientific journals and participation in specialized professional committees further demonstrate her leadership in shaping research directions in oral medicine, prosthodontics, and biomaterials science. Through her innovations, Professor Wu has significantly advanced clinical applications and material technologies in modern stomatology.

Citation Metrics (Scopus)
800

600

400

200

0

Citations
719

Documents
50

h-index
15

Citations
Documents
h-index



View Scopus Profile


Featured Publications

Ioan Tomuta | Genetic Material | Research Excellence Award

Prof. Dr. Ioan Tomuta | Genetic Material | Research Excellence Award

University of Medicine and Pharmacy Iuliu Hatieganu Cluj-Napoca | Romania

Ioan Tomuță is a leading researcher in pharmaceutical technology with extensive expertise in the design, development, and optimization of modern dosage forms. His work focuses on understanding the physicochemical and mechanical properties of active substances and excipients, their processing behavior, and their influence on drug release kinetics and bioavailability. He has made significant contributions to advanced drug delivery systems, including liposomes, nanoparticles, polymeric films, and gastroretentive drug delivery platforms produced through 3D printing. His research also advances the use of NIR spectroscopy, chemometrics, and Quality-by-Design principles for pharmaceutical development and process analytical control. He has played key roles in national and European research projects involving process engineering, tissue regeneration technologies, and artificial intelligence–based prediction tools for 3D-printable medicines. His work spans formulation science, process optimization, GMP-oriented industrial applications, and innovation in personalized medicine manufacturing technologies.

Profiles: Google Scholar | Scopus | Orcid

Featured Publications: 

Savencu, I., Iurian, S., Porfire, A., Bogdan, C., & Tomuță, I. (2021). Review of advances in polymeric wound dressing films. Reactive and Functional Polymers, 168, 105059.

Ilyés, K., Kovács, N. K., Balogh, A., Borbás, E., Farkas, B., Casian, T., Marosi, G., … & Tomuță, I. (2019). The applicability of pharmaceutical polymeric blends for the fused deposition modelling (FDM) 3D technique: Material considerations, printability, process modulation, with particular interest in additive manufacturing applications. European Journal of Pharmaceutical Sciences, 129, 110–123.

Tefas, L. R., Sylvester, B., Tomuță, I., Sesarman, A., Licarete, E., Banciu, M., … & Porfire, A. (2017). Development of antiproliferative long-circulating liposomes co-encapsulating doxorubicin and curcumin through the use of a quality-by-design approach. Drug Design, Development and Therapy, 1605–1621.

Tefas, L. R., Tomuță, I., Achim, M., & Vlase, L. (2015). Development and optimization of quercetin-loaded PLGA nanoparticles by experimental design. Clujul Medical, 88(2), 214.

Barbalata, C. I., Tefas, L. R., Achim, M., Tomuță, I., & Porfire, A. S. (2020). Statins in risk-reduction and treatment of cancer. World Journal of Clinical Oncology, 11(8), 573.

Bogdan, C., Iurian, S., Tomuță, I., & Moldovan, M. (2017). Improvement of skin condition in striae distensae: Development, characterization and clinical efficacy of a cosmetic product containing Punica granatum seed oil and Croton lechleri resin extract. Drug Design, Development and Therapy, 521–531.

Rusu, M. E., Gheldiu, A. M., Mocan, A., Moldovan, C., Popa, D. S., Tomuță, I., … & Vlase, L. (2018). Process optimization for improved phenolic compounds recovery from walnut (Juglans regia L.) septum: Phytochemical profile and biological activities. Molecules, 23(11), 2814.

Colobatiu, L., Gavan, A., Potarniche, A. V., Rus, V., Diaconeasa, Z., Mocan, A., … & Tomuță, I. (2019). Evaluation of bioactive compounds-loaded chitosan films as a novel and potential diabetic wound dressing material. Reactive and Functional Polymers, 145, 104369.

Rusu, M. E., Fizeșan, I., Pop, A., Gheldiu, A. M., Mocan, A., Crișan, G., Vlase, L., … & Tomuță, I. (2019). Enhanced recovery of antioxidant compounds from hazelnut (Corylus avellana L.) involucre based on extraction optimization: Phytochemical profile and antioxidant activity. Antioxidants, 8(10), 460

Meenakshi | Signal Transduction Networks | Research Excellence Award

Assoc. Prof. Dr. Meenakshi | Signal Transduction Networks | Research Excellence Award

Chandigarh University | India

Dr. Meenakshi Munjal is an active researcher in the field of wireless communication, contributing extensively to advancements in emerging communication technologies. Over the past several years, she has maintained a strong research trajectory, completing one funded research project and producing a substantial body of scholarly work. Her research output includes more than 30 Scopus-indexed publications and a total citation count of 100, reflecting the growing impact of her contributions within the scientific community. She has authored one book with an ISBN and has two patents published or under process, demonstrating her commitment to innovation and applied research in communication systems. In addition to her publications, she has published eight peer-reviewed journal articles across SCI and Scopus-indexed platforms, strengthening the scientific understanding of wireless networks, signal processing, and communication technologies. Her work aligns with contemporary challenges in wireless systems, contributing to enhanced network performance, reliability, and efficiency. She also holds three professional memberships, supporting collaborative engagement within the research ecosystem. Overall, her research contributions highlight a sustained focus on innovation, scholarly excellence, and the advancement of wireless communication technologies

Profiles: Google Scholar | Scopus | Orcid

Featured Publications: 

Munjal, M., & Singh, N. P. (2018). Utility aware network selection in small cell. Wireless Networks, 1–14.

Munjal, M., & Singh, N. P. (2019). Group mobility by cooperative communication for high speed railway. Wireless Networks, 25(7), 3857–3866.

Gupta, S. (2014). A review and comprehensive comparison of image denoising techniques. Proceedings of the International Conference on Computing for Sustainable Global Development, 1–6.

Munjal, M., & Singh, N. P. (2019). QoS and cost-aware protocol selection for next generation wireless network. Journal of Network and Systems Management, 27(2), 327–350.

Munjal, M., & Singh, N. P. (2017). Improved network selection for multimedia applications. Transactions on Emerging Telecommunications Technologies, 28(5), e3121.

Munjal, M., & Singh, N. P. (2016). A comparative study of cooperative and non-cooperative game theory in network selection. Computational Techniques in Information and Communication Technologies Conference Proceedings, 1–5.

Meenakshi, G., & Gupta, S. (2014). Advanced level cyclic gray codes with application. International Journal of Electronics Communication and Computer Technology, 1–6.

Munjal, M., & Singh, N. P. (2020). Low cost communication for high speed railway. Wireless Personal Communications, 111(1), 163–178.

Munjal, M. (2024). A comprehensive review of wireless body area network in medical applications. AIP Conference Proceedings, 3100(1), 040013.

Munjal, M., & Dev, S. (2021). Utility based handoff decision for Internet of Everything (IoE). Photonics & Electromagnetics Research Symposium (PIERS) Proceedings, 1396–1405.

Singh, I., & Munjal, M. (2025). Intelligent network selection mechanisms in the Internet of Everything system. IEEE Access.

Munjal, M., Kaistha, K., Gupta, P., Sardana, L., Verma, R., & Verma, S. (2024). Handoff management using RSS in a heterogeneous system. AIP Conference Proceedings, 3072(1), 030003.

Junning Ma | Cell Surface Receptors | Best Research Article Award

Dr. Junning Ma | Cell Surface Receptors | Best Research Article Award

Zhejiang University | China

Dr. Junning Ma has developed a multidisciplinary portfolio spanning neurosurgery, neural engineering, biomaterials, and nanomedicine. Their work integrates neural stem cell biology, targeted drug delivery, and tumor microenvironment modulation to create innovative therapeutic strategies for brain diseases. They have conducted advanced postdoctoral and doctoral research at major institutions, contributing to National Natural Science Foundation of China (NSFC) Youth Fund projects and multiple US-funded NIH and AHA grants. Their research focuses on biomimetic nanocarriers, including cell membrane-coated nanoparticles, PLGA-based delivery systems, and fusion-membrane technologies designed for precision therapy of glioma, pituitary adenoma, and ischemic stroke.

Key projects include engineered neural stem cell membrane-coated nanoparticles for stroke targeting, biomimetic nanoplatforms for cancer immunotherapy, and tumor microenvironment–responsive delivery systems. They have also contributed to studies on neuromodulation, neurotrophic factor-based therapy, neural stem cell transplantation, and photothrombotic stroke models. Their publication record includes high-impact journals such as Materials Today Bio, Biomaterials, Nano Letters, Small, and Cell Reports Physical Science, covering topics like vascular-targeting nanoclusters, polyphenol nanoparticles, and membrane-engineered carriers.

Overall, their research advances translational nanomedicine and regenerative neuroscience, with an emphasis on targeted therapies capable of overcoming the challenges of brain tumor heterogeneity, the blood–brain barrier, and ischemic neural injury.

Profiles: Scopus | Orcid

Featured Publications: 

Ma, J., Win, Y., Xiaojian, Z., et al. (2023). Enhanced EPR effects by folliculostellate cell membrane–coated nanoparticles on invasive pituitary adenoma. Materials Today Bio.

Ma, J., Dai, L., Jianbo, Y., et al. (2023). Tumor microenvironment targeting system for glioma treatment via fusion cell membrane coating nanotechnology. Biomaterials.

Ma, J., Liu, F., Wendy, C., et al. (2020). Co-presentation of tumor antigens with costimulation via biomimetic nanoparticles for effective cancer immunotherapy. Nano Letters.

Ma, J., Zhang, S., Jun, L., et al. (2019). Targeted drug delivery to stroke via chemotactic recruitment of nanoparticles coated with membranes of engineered neural stem cells. Small.

Ilaria Cossu | Immunology Cellular Interactions | Research Excellence Award

Ms. Ilaria Cossu | Immunology Cellular Interactions | Research Excellence Award

University of Sassari | Italy

Ilaria Cossu is a motivated PhD candidate in Life Sciences and Biotechnologies with a specialization in Microbiology and Immunology. Their work focuses on understanding the role of human endogenous retroviruses (HERVs) in cancer, integrating molecular biology, immunology, and virology approaches to explore how retroviral elements may influence tumorigenesis. Their doctoral project involves conducting indirect ELISA assays, maintaining and analyzing cell cultures, processing blood samples, performing RNA extraction and reverse transcription, and carrying out quantitative PCR for gene expression profiling. The researcher is actively engaged in experimental design, data analysis, scientific writing, and collaborative research activities at both national and international levels.

Prior academic training includes Master’s and Bachelor’s degrees in Biology, each completed with top distinction, and research internships in microbiology, virology, and biochemistry laboratories. These experiences provided hands-on expertise in electrophoretic methods such as cellulose acetate electrophoresis, C-PAGE, fluorescent 2-aminoacridone probe (FACE) analysis, and SDS-PAGE, contributing to a solid foundation in protein and nucleic acid characterization. Their current research aims to advance understanding of retroviral contributions to cancer biology and supports the development of innovative molecular approaches for disease investigation and potential therapeutic insights.

Profile: Scopus

Featured Publications:

Cossu, I., Ruberto, S., Filippi, E., Simula, E. R., Noli, M., Mottula, A., & others. (2025). HERV-K envelope induces a humoral response in Non-Hodgkin lymphoma patients. Current Microbiology, 82(12), 574.

Jasemi, S., Molicotti, P., Fais, M., Cossu, I., Simula, E. R., Sechi, L. A., & others. (2025). Biological mechanisms of enterotoxigenic Bacteroides fragilis toxin: Linking inflammation, colorectal cancer, and clinical implications. Toxins, 17(6), 305.

Simula, E. R., Jasemi, S., Cossu, D., Fais, M., Cossu, I., Chessa, V., & others. (2025). Human endogenous retroviruses as novel therapeutic targets in neurodegenerative disorders. Vaccines, 13(4), 415. h

Ruberto, S., Santovito, A., Caviglia, G. P., Noli, M., Cossu, D., Ribaldone, D. G., & others. (2025). Mycobacterium avium subsp. paratuberculosis and human endogenous retrovirus in Italian patients with inflammatory bowel disease and irritable bowel syndrome. Immunology.

Ran Wang | Pulmonary Hypertension | Best Researcher Award

Prof. Dr. Ran Wang | Pulmonary Hypertension | Best Researcher Award

First Affiliated Hospital of Anhui Medical University | China

Dr. Ran Wang is an accomplished respiratory medicine researcher whose work has significantly advanced the understanding of pulmonary hypertension and chronic obstructive pulmonary disease (COPD). With more than two decades of clinical and scientific experience, he has extensively investigated the molecular mechanisms underlying hypoxic pulmonary hypertension and COPD pathogenesis. His research has contributed to improved insights into vascular remodeling, inflammatory signaling, and pulmonary vascular resistance, helping to strengthen the scientific basis for future diagnostic and therapeutic strategies.

He has successfully led multiple high-impact research projects, including two funded by the National Natural Science Foundation and three additional provincial-level studies. His work spans basic, translational, and clinical domains, integrating experimental models with patient-centered research to address key challenges in pulmonary vascular diseases. He has authored or co-authored 59 peer-reviewed journal articles, including over 50 SCI-indexed publications and more than 20 as first or corresponding author. His research outputs include four patents related to respiratory disease mechanisms and clinical application innovations.

In addition to his scholarly publications, he serves on editorial boards of leading journals such as Journal of Cancer Research and Clinical Oncology, BMC Pulmonary Medicine, and Cancer Control, contributing to the advancement of scientific discourse in respiratory and cancer research.

Profile: Scopus

Featured Publications:

  • Han, R., Guan, Y., Li, P., Tang, M., Fei, G., Zeng, D., & Wang, R. (2025). Real-world efficacy of oral azvudine in hospitalized patients with COVID-19: A multicenter retrospective cohort study. Journal of Infection and Public Health, 18(12), 102987.

  • Liu, Y., Wang, R., & Jiang, T. (2025). RNA-binding proteins as a molecular link between COPD and pulmonary hypertension. International Journal of Medical Sciences, 22(8), 1979–1991.

  • Rao, B., Wang, D., Yang, M., … et al. (2025). Real-world effectiveness and safety of oral Azvudine versus Paxlovid for COVID-19 in patients with kidney disease: A multicenter, retrospective, cohort study. BMC Infectious Diseases, 25, 275.